FDA: Epilepsy drug may be risky for Asians

piggy submitted, created time 1 month 1 week (www.fda.gov)

FDA is investigating new preliminary data regarding a potential increased risk of serious skin reactions including Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) from phenytoin therapy in Asian patients positive for a particular human leukocyte antigen (HLA) allele, HLA-B*1502. This allele occurs almost exclusively in patients with ancestry across broad areas of Asia, including Han Chinese, Filipinos, Malaysians, South Asian Indians, and Thais

Submit comment | Blog It | Email It | Keywords: Stevens Johnson syndrome SJS TEN toxic epidermal necrolysis dermatology skin demographics race epilepsy HLA-B*1502 epilepsy therapy FDA